Saakshi Medtech and Panels Limited Issues Updated Valuation Report for Preferential Issue
Saakshi Medtech and Panels Limited has received an updated valuation report from a Registered Valuer regarding the preferential issue of equity shares on a consideration other than cash basis. The update follows the shareholders' approval obtained during the Extraordinary General Meeting held on June 2, 2026.The revised valuation was prepared based on the latest audited financial statements of the concerned entities and assets. Following a review by the Board and Management, it was determined that the updated valuation is based on audited financial information and supports the fair value of the assets or securities proposed to be acquired under the preferential allotment.
The company confirmed that the updated valuation does not materially alter the terms of the preferential issue approved by shareholders. Furthermore, there is no change in the swap of shares or the issuance price.
Saakshi Medtech and Panels Limited has made this update available for review to ensure transparency for shareholders and investors. The full Valuation Report is accessible on the company's official website.
SAAKSHI Stock Price Movement
Saakshi Medtech and Panels Limited shares rallied today to settle at ₹295, gaining 0.82% in post-market trading. The move saw the stock trade with a volume of 7,800 shares as it held steady above its opening price.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.